BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19050679)

  • 1. Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer.
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    Asian J Androl; 2009 Jan; 11(1):131-7. PubMed ID: 19050679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    Eur Urol; 2007 Jan; 51(1):121-8; discussion 128-9. PubMed ID: 16797831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy.
    Hsu CY; Wildhagen MF; Van Poppel H; Bangma CH
    BJU Int; 2010 Jun; 105(11):1536-40. PubMed ID: 19912180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors.
    Joniau S; Hsu CY; Gontero P; Spahn M; Van Poppel H
    Scand J Urol Nephrol; 2012 Jun; 46(3):164-71. PubMed ID: 22364377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients.
    Park JW; Koh DH; Jang WS; Lee JY; Cho KS; Ham WS; Rha KH; Jung WH; Hong SJ; Choi YD
    PLoS One; 2018; 13(6):e0199365. PubMed ID: 29924851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.
    Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D
    BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
    Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transrectal ultrasound in the staging of clinical T3a prostate cancer.
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    Eur J Surg Oncol; 2007 Feb; 33(1):79-82. PubMed ID: 17067773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of D'Amico criteria for low-risk prostate cancer.
    Milonas D; Kinčius M; Skulčius G; Matjošaitis AJ; GudinavičienĖ I; Jievaltas M
    Scand J Urol; 2014 Aug; 48(4):344-9. PubMed ID: 24521187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.
    Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
    Ann Surg Oncol; 2014 Feb; 21(2):677-83. PubMed ID: 24145996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
    Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
    Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
    Sivaraman A; Ordaz Jurado G; Cathelineau X; Barret E; Dell'Oglio P; Joniau S; Bianchi M; Briganti A; Spahn M; Bastian P; Chun J; Chlosta P; Gontero P; Graefen M; Jeffrey Karnes R; Marchioro G; Tombal B; Tosco L; van der Poel HH; Sanchez-Salas R
    World J Urol; 2016 Oct; 34(10):1367-72. PubMed ID: 26897499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age.
    Tilki D; Maurer V; Pompe RS; Chun FK; Preisser F; Haese A; Graefen M; Huland H; Mandel P
    World J Urol; 2020 Jan; 38(1):95-101. PubMed ID: 30937571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of clinical unilateral T3a prostate cancer - by digital rectal examination or transrectal ultrasonography?
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    BJU Int; 2006 Nov; 98(5):982-5. PubMed ID: 16945120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.